ADAMIO regulates endothelial permeability and T-cell transmigration by proteolysis of vascular endothelial cadherin

Circulation Research

Volumn 102, Issue 10, 2008, Pages 1192-1201

  Schulz, Beate ^a   Pruessmeyer, Jessica ^b   Maretzky, Thorsten ^c   Ludwig, Andreas ^b   Blobel, Carl P ^c   Saftig, Paul ^a   Reiss, Karina ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Endothelial permeability; Endothelium; Metalloprotease; VE cadherin

Indexed keywords

A DISINTEGRIN AND METALLOPROTEASE PROTEIN 10; ADAM PROTEIN; CALCIUM ION; GAMMA SECRETASE; PROTEIN KINASE C; SMALL INTERFERING RNA; STAUROSPORINE; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL CADHERIN; ADAM10 PROTEIN, HUMAN; CADHERIN; CALCIUM; ENZYME INHIBITOR; HEMOSTATIC AGENT; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN; SECRETASE; THROMBIN;

APOPTOSIS; ARTICLE; CALCIUM TRANSPORT; CARBOXY TERMINAL SEQUENCE; CELL ACTIVATION; CELL ADHESION; CELL FUNCTION; CELL JUNCTION; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; DISSOLUTION; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME SUBSTRATE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; LEUKOCYTE MIGRATION; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROCESSING; REGULATORY MECHANISM; RNA INTERFERENCE; T LYMPHOCYTE; CAPILLARY PERMEABILITY; CELL CULTURE; CELL MOTION; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; IMMUNOLOGY; LEUKOCYTE ROLLING; METABOLISM; PHYSIOLOGY; UMBILICAL VEIN;

ADAM PROTEINS; ADHERENS JUNCTIONS; AMYLOID PRECURSOR PROTEIN SECRETASES; ANTIGENS, CD; CADHERINS; CALCIUM; CAPILLARY PERMEABILITY; CELL MOVEMENT; CELLS, CULTURED; ENDOTHELIAL CELLS; ENZYME INHIBITORS; HEMOSTATICS; HUMANS; LEUKOCYTE ROLLING; MEMBRANE PROTEINS; PROTEIN KINASE C; RNA, SMALL INTERFERING; T-LYMPHOCYTES; THROMBIN; UMBILICAL VEINS;

EID: 45149117638     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.107.169805     Document Type: Article

References (38)

1. Vincent PA, Xiao K, Buckley KM, Kowalczyk AP. VE-cadherin: adhesion at arm's length. Am J Physiol Cell Physiol. 2004;286: C987-C997.
2. Rabiet MJ, Plantier JL, Rival Y, Genoux Y, Lampugnani MG, Dejana E. Thrombin-induced increase in endothelial permeability is associated with changes in cell-to-cell junction organization. Arterioscler Thromb Vasc Biol. 1996;16:488-496.
3. Carden D, Xiao F, Moak C, Willis BH, Robinson-Jackson S, Alexander S. Neutrophil elastase promotes lung microvascular injury and proteolysis of endothelial cadherins. Am J Physiol. 1998;275:H385-H392.
4. Baumgartner I, Rauh G, Pieczek A, Wuensch D, Magner M, Kearney M, Schainfeld R, Isner JM. Lower-extremity edema associated with gene transfer of naked DNA encoding vascular endothelial growth factor. Ann Intern Med. 2000;132:880-884.
5. Dejana E, Spagnuolo R, Bazzoni G. Interendothelial junctions and their role in the control of angiogenesis, vascular permeability and leukocyte transmigration. Thromb Haemost. 2001;86:308-315.
6. Shaw SK, Bamba PS, Perkins BN, Luscinskas FW. Real-time imaging of vascular endothelial-cadherin during leukocyte transmigration across en-dothelium. J Immunol. 2001;167:2323-2330.
7. Herren B, Levkau B, Raines EW, Ross R. Cleavage of beta-catenin and plakoglobin and shedding of VE-cadherin during endothelial apoptosis: evidence for a role for caspases and metalloproteinases. Mol Biol Cell. 1998;9:1589-1601.
8. Soeki T, Tamura Y, Shinohara H, Sakabe K, Onose Y, Fukuda N. Elevated concentration of soluble vascular endothelial cadherin is associated with coronary atherosclerosis. Circ J. 2004;68:1-5.
9. Navaratna D, McGuire PG, Menicucci G, Das A. Proteolytic degradation of VE-cadherin alters the blood-retinal barrier in diabetes. Diabetes. 2007;56:2380-2387.
10. Reiss K, Ludwig A, Saftig P. Breaking up the tie: disintegrin-like metalloproteinases as regulators of cell migration in inflammation and invasion. Pharmacol Ther. 2006;111:985-1006.
11. Horiuchi K, Zhou HM, Kelly K, Manova K, Blobel CP. Evaluation of the contributions of ADAMs 9, 12, 15, 17, and 19 to heart development and ectodomain shedding of neuregulins betal and beta2. Dev Biol. 2005; 283:459-471.
12. Peschon JJ, Slack JL, Reddy P, Stocking KL, Sunnarborg SW, Lee DC, Russell WE, Castner BJ, Johnson RS, Fitzner JN, Boyce RW, Nelson N, Kozlosky CJ, Wolfson MF, Rauch CT, Cerretti DP, Paxton RJ, March CJ, Black RA. An essential role for ectodomain shedding in mammalian development. Science. 1998;282:1281-1284.
13. Sahin U, Weskamp G, Kelly K, Zhou HM, Higashiyama S, Peschon J, Hartmann D, Saftig P, Blobel CP. Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands. J Cell Biol. 2004;164:769-779.
14. Hartmann D, de Strooper B, Serneels L, Craessaerts K, Herreman A, Annaert W, Umans L, Lubke T, Lena IA, von Figura K, Saftig P. The disintegrin/ metalloprotease ADAM 10 is essential for Notch signalling but not for alpha-secretase activity in fibroblasts. Hum Mol Genet. 2002; 11:2615-2624.
15. Reiss K, Maretzky T, Ludwig A, Tousseyn T, de Strooper B, Hartmann D, Saftig P. ADAM10 cleavage of N-cadherin and regulation of cell-cell adhesion and beta-catenin nuclear signalling. EMBO J. 2005;24:742-752.
16. Ludwig A, Hundhausen C, Lambert MH, Broadway N, Andrews RC, Bickett DM, Leesnitzer MA, Becherer JD. Metalloproteinase inhibitors for the disintegrin-like metalloproteinases ADAM10 and ADAM17 that differentially block constitutive and phorbol ester-inducible shedding of cell surface molecules. Comb Chem High Throughput Screen. 2005;8: 161-171.
17. Merlos-Suarez A, Ruiz-Paz S, Baselga J, Arribas J. Metalloprotease- dependent protransforming growth factor-alpha ectodomain shedding in the absence of tumor necrosis factor-alpha-converting enzyme. J Biol Chem. 2001;276:48510-48517.
18. Breviario F, Caveda L, Corada M, Martin-Padura I, Navarro P, Golay J, Introna M, Gulino D, Lampugnani MG, Dejana E. Functional properties of human vascular endothelial cadherin (7B4/cadherin-5), an endotheli-um-specific cadherin. Arterioscler Thromb Vasc Biol. 1995; 15: 1229-1239.
19. Lampugnani MG, Corada M, Caveda L, Breviario F, Ayalon O, Geiger B, Dejana E. The molecular organization of endothelial cell to cell junctions: differential association of plakoglobin, beta-catenin, and alpha-catenin with vascular endothelial cadherin (VE-cadherin). J Cell Biol. 1995;129: 203-217.
20. Boulday G, Coupel S, Coulon F, Soulillou JP, Charreau B. Antigraft antibody-mediated expression of metalloproteinases on endothelial cells. Differential expression of TIMP-1 and ADAM-10 depends on antibody specificity and isotype. Circ Res. 2001;88:430-437.
21. Sandoval R, Malik AB, Minshall RD, Kouklis P, Ellis CA, Tiruppathi C. Ca(2 +) signalling and PKCalpha activate increased endothelial permeability by disassembly of VE-cadherin junctions. J Physiol. 2001;533: 433-445.
22. Yamada Y, Furumichi T, Furui H, Yokoi T, Ito T, Yamauchi K, Yokota M, Hayashi H, Saito H. Roles of calcium, cyclic nucleotides, and protein kinase C in regulation of endothelial permeability. Arteriosclerosis. 1990; 10:410-420.
23. Bussolino F, Camussi G, Aglietta M, Braquet P, Bosia A, Pescarmona G, Sanavio F, D'Urso N, Marchisio PC. Human endothelial cells are target for platelet-activating factor. I. Platelet-activating factor induces changes in cytoskeleton structures. J Immunol. 1987;139:2439-2446.
24. Vouret-Craviari V, Boquet P, Pouyssegur J, Obberghen-Schilling E. Regulation of the actin cytoskeleton by thrombin in human endothelial cells: role of Rho proteins in endothelial barrier function. Mol Biol Cell. 1998;9:2639-2653.
25. Aurrand-Lions M, Johnson-Leger C, Imhof BA. The last molecular fortress in leukocyte trans-endothelial migration. Nat Immunol. 2002;3: 116-118.
26. Marambaud P, Wen PH, Dutt A, Shioi J, Takashima A, Siman R, Robakis NK. A CBP binding transcriptional repressor produced by the PS1/epsilon-cleavage of N-cadherin is inhibited by PS 1 FAD mutations. Cell. 2003;114:635-645.
27. Navarro P, Ruco L, Dejana E. Differential localization of VE- and N-cadherins in human endothelial cells: VE-cadherin competes with N-cadherin for junctional localization. J Cell Biol. 1998;140:1475-1484.
28. Dejana E. Endothelial cell-cell junctions: happy together. Nat Rev Mol Cell Biol. 2004;5:261-270.
29. Garcia JG, Pavalko FM, Patterson CE. Vascular endothelial cell activation and permeability responses to thrombin. Blood Coagul Fibrinolysis. 1995;6:609-626.
30. Horgan MJ, Fenton JW, Malik AB. Alpha-thrombin-induced pulmonary vasoconstriction. J Appl Physiol. 1987;63:1993-2000.
31. van Nieuw Amerongen GP, Beckers CM, Achekar ID, Zeeman S, Musters RJ, van Hinsbergh VW. Involvement of Rho kinase in endothelial barrier maintenance. Arterioscler Thromb Vasc Biol. 2007;27: 2332-2339.
32. Del Maschio A, Zanetti A, Corada M, Rival Y, Ruco L, Lampugnani MG, Dejana E. Polymorphonuclear leukocyte adhesion triggers the disorganization of endothelial cell-to-cell adherens junctions. J Cell Biol. 1996; 135:497-510.
33. Allport JR, Ding H, Collins T, Gerritsen ME, Luscinskas FW. Endothe-lial-dependent mechanisms regulate leukocyte transmigration: a process involving the proteasome and disruption of the vascular endothelial-cadherin complex at endothelial cell-to-cell junctions. J Exp Med. 1997; 186:517-527.
34. Liu Y, Shaw SK, Ma S, Yang L, Luscinskas FW, Parkos CA. Regulation of leukocyte transmigration: cell surface interactions and signaling events. J Immunol. 2004;172:7-13.
35. Allport JR, Muller WA, Luscinskas FW. Monocytes induce reversible focal changes in vascular endothelial cadherin complex during transen-dothelial migration under flow. J Cell Biol. 2000;148:203-216.
36. Huang AJ, Manning JE, Bandak TM, Ratau MC, Hanser KR, Silverstein SC. Endothelial cell cytosolic free calcium regulates neutrophil migration across monolayers of endothelial cells. J Cell Biol. 1993; 120:1371-1380.
37. Schulte M, Reiss K, Lettau M, Maretzky T, Ludwig A, Hartmann D, de Strooper B, Janssen O, Saftig P. ADAMIO regulates FasL cell surface expression and modulates FasL-induced cytotoxicity and activation-induced cell death. Cell Death Differ. 2007;14:1040-1049.
38. Janes PW, Saha N, Barton WA, Kolev MV, Wimmer-Kleikamp SH, Nievergall E, Blobel CP, Himanen JP, Lackmann M, Nikolov DB. Adam meets Eph: an ADAM substrate recognition module acts as a molecular switch for ephrin cleavage in trans. Cell. 2005;123:291-304.